Wijaya, A, A(外),Wijaya,Maruf,王贵学.Recent advances in micro- and nano-bubbles for atherosclerosis applications:BIOMATERIALS SCIENCE,2020,8):4920-4939

王溢,李天函(学),张康(外),Maruf, A(外),覃弦(学),罗力(学),邱菊辉,钟元(学),McGinty, S(外),Pontrelli, G(外),Liao, XL(外),吴伟.Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications:THERANOSTICS,2020,11):164-180

彭仁义,嵇豪(外),彭仁义(外),金立波(外),Lin Sue(外),Huang Yijiang(外),Xu Ke(外),Yang Qin-Si(外),孙达(外),吴伟.Macrophage-Based Therapies for Atherosclerosis Management:JOURNAL OF IMMUNOLOGY RESEARCH,2020,2020(2020):8131754

邱菊辉,侯郑军(学),严文华(学),李天函(学),吴伟,崔玉良(学),张筱娟,陈猷鹏,尹铁英,王贵学.Lactic acid-mediated endothelial to mesenchymal transition through TGF-beta 1 contributes to in-stent stenosis in poly-L-lactic acid stent:INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,2020,155):1589-1598

孙达,陈佳(外),孙达(外),吴伟,Tang Ju(外),罗力(学),张坤(学),金立波(外),Lin Sue(外),Gao Yitian(外),Yan Xiaoqing(外),Zhang Chi(外).MiR-802 causes nephropathy by suppressing NE-kappa B-repressing factor in obese mice and human:JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,23):2863-2871

孙达,陈佳(外),孙达(外),王园(外),彭仁义(外),嵇豪(外),金立波(外).Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery:THERANOSTICS,2019,9):6885-6900

王溢,张康(学),王溢(学),覃弦(学),李天函(学),邱菊辉,尹铁英,黄俊丽,McGinty, S(外),Pontrelli, G(外),Ren, J(外),Wang, QW(外),王贵学.Biomimetic Nanotherapies: Red Blood Cell Based Core-Shell Structured Nanocomplexes for Atherosclerosis Management:ADVANCED SCIENCE,6):-

钟元,王溢(学),钟元(学),罗力(学),Nurhidayah Deti(外),Maruf, Ali(外),Gregersen Hans(外),吴伟.Targeted polyethylenimine/(p53 plasmid) nanocomplexes for potential antitumor applications:NANOTECHNOLOGY,30):-

Ali Maruf,王溢(学),Ali Maruf(外),尹铁英,黄俊丽,Wang Nan(外),Durkan Colm(外),Tan Youhua(外),吴伟.Atherosclerosis Treatment with Stimuli-Responsive Nanoagents: Recent Advances and Future Perspectives:ADVANCED HEALTHCARE MATERIALS,8):1900036

罗力,吴伟,罗力(学),孙达(外),代菡镔(学),王溢(学),钟元(学),王瑾瑄(学),Maruf Ali(外),Deti Nurhidayah(外),张筱娟,王颖.Acid-Activated Melittin for Targeted and Safe Antitumor Therapy:BIOCONJUGATE CHEMISTRY,29(9):2936-2944